AWARDDELIVERY ORDERSmall business
Delivery order 75F40125F19019VERSATECH/IMPYRIAN TECHNOLOGY NETWORK LLC
Overview
Award facts
- Net obligations
- $1.89M
- $1,888,081of $2.04M potential value
- Outlays (paid to date)
- $895.68K
- $895.68K paid of $1.89M obligated$895,680
- Period of performance
- Sep 30, 2025 to Sep 29, 2026
- Ended
- Modifications
- 0
- Latest action Sep 30, 2025
- Contract type
- Delivery order
- PIID 75F40125F19019
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
AUDIO VISUAL (AV) TECHNICAL REFRESH FOR THE FDA EMERGENCY OPERATIONS CENTER (EOC)
Dates and value
- Award date
- Signed on Sep 30, 2025
- Potential end of performance
- Sep 28, 2026
- Current value
- $1,888,081Base and exercised options
- Potential value (if all options are exercised)
- $2,036,397
- Parent contract vehicle
- 75F40122D00024 (IDC, single award) — 25 orders recorded under it
Obligations by fiscal year of action
- FY2025: $1,888,081
Total across 1 fiscal year: $1,888,081
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 30, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationFULTON, MD
UEIX5MLBQJH1WZ4
CAGE code7T0Q8
Business sizeSmall businessSize at award, per the contracting officer
Organization typePartnership
Parent companyVERSATECH/IMPYRIAN TECHNOLOGY NETWORK LLC
Business types and certifications
Self-certified small disadvantaged business8(a) joint ventureFor-profit organizationLimited liability companyPartnership or LLP
As represented in SAM.gov at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Foods; Human drugs; Devices and radiological health; National center for toxicological research; Fda other activities (fda headquaters); Animal drugs and feed; Biologics; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Silver Spring, Montgomery County, Maryland 20993-0002
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- DA01IT AND TELECOM - BUSINESS APPLICATION/APPLICATION DEVELOPMENT SUPPORT SERVICES (LABOR) (service)
Competition
- Extent competed
- Not available for competitionB
- Reason not competed
- Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- Not reported
- Contract pricing
- Time and materialsY
Solicitation and notices
- Solicitation ID
- 75F40125R00126(as reported)
- Solicitation date
- Sep 17, 2025
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- Yes
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Transaction history
Modification history
- Base award
- Sep 30, 2025Base obligation at award: $1,888,081
- Latest action
- Sep 30, 2025 — Base awardModification 0; obligation change +$1,888,081
- Actions by type
- Base award1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $1,888,081
- Latest action: change in base and all options
- $2,036,397
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 1
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2025/2025-0600-000
- 075-X-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression